retatrutide phase 2 trial weight loss for Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide for weight loss: Study

The needle is hidden inside the cover, so it is not visible

The study provides the first characterization of nationwide GLP-1 use and spending among individuals without diabetes to guide ongoing debates about balancing the sustainability of health care spending against improving accessibility and affordability of GLP-1 medications going forward, researchers concluded

Regulatory Approval Rationale The European Medicines Agency (EMA) granted approval for Ozempic based on its demonstrated efficacy in glycemic control, associated weight reduction benefits, and potential to reduce diabetes-related cardiovascular complications

It has not been approved by the MHRA (Medicines and Healthcare products Regulatory Agency) , so it cannot legally be prescribed or dispensed in the UK privately or on the NHS regardless of any claims made online